Tissue-specific enhancer-promoter interactions regulate high level constitutive expression of matrix metalloproteinase 2 by glomerular mesangial cells.
about
Co-operative interactions between NFAT (nuclear factor of activated T cells) c1 and the zinc finger transcription factors Sp1/Sp3 and Egr-1 regulate MT1-MMP (membrane type 1 matrix metalloproteinase) transcription by glomerular mesangial cellsA functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimersThe hematopoietic transcription factor PU.1 represses gelatinase A transcription in glomerular mesangial cellsDiscoidin domain receptor 2 interacts with Src and Shc following its activation by type I collagenA synergistic interaction of transcription factors AP2 and YB-1 regulates gelatinase A enhancer-dependent transcriptionTumour metastasis suppressor, nm23-beta, inhibits gelatinase A transcription by interference with transactivator Y-box protein-1 (YB-1)Discoidin domain receptor 2 regulates fibroblast proliferation and migration through the extracellular matrix in association with transcriptional activation of matrix metalloproteinase-2Mesangial cell gelatinase A synthesis is attenuated by oscillating hyperbaric pressureCombinatorial interactions of p53, activating protein-2, and YB-1 with a single enhancer element regulate gelatinase A expression in neoplastic cells.FRNK blocks v-Src-stimulated invasion and experimental metastases without effects on cell motility or growth.Inhibition of proliferation, migration and proteolysis contribute to corticosterone-mediated inhibition of angiogenesisTwo Distinct Isoforms of Matrix Metalloproteinase-2 Are Associated with Human Delayed Kidney Graft Function.Gentamicin supplemented polyvinylidenfluoride mesh materials enhance tissue integration due to a transcriptionally reduced MMP-2 protein expression.Alveolar macrophages and emphysema in surfactant protein-D-deficient mice.Connective tissue growth factor regulates retinal neovascularization through p53 protein-dependent transactivation of the matrix metalloproteinase (MMP)-2 geneGlomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1.Overproduction of reactive oxygen species - obligatory or not for induction of apoptosis by anticancer drugsSuppressor and activator functions mediated by a repeated heptad sequence in the liver fatty acid-binding protein gene (Fabpl). Effects on renal, small intestinal, and colonic epithelial cell gene expression in transgenic mice.Expression of the recessive glomerulosclerosis gene Mpv17 regulates MMP-2 expression in fibroblasts, the kidney, and the inner ear of mice.Cold shock Y-box protein-1 proteolysis autoregulates its transcriptional activities.Transcriptional activation by p53 of the human type IV collagenase (gelatinase A or matrix metalloproteinase 2) promoter.The amyloid-beta peptide suppresses transforming growth factor-beta1-induced matrix metalloproteinase-2 production via Smad7 expression in human monocytic THP-1 cells.Matrix metalloproteinase 2 (MMP2) and MMP9 are produced by kidney collecting duct principal cells but are differentially regulated by SV40 large-T, arginine vasopressin, and epidermal growth factor.The CCAAT box binding factor, NF-Y, is required for thyroid hormone regulation of rat liver S14 gene transcription.Cardiac ischemia-reperfusion injury induces matrix metalloproteinase-2 expression through the AP-1 components FosB and JunB.Role of metalloproteinases in the development and healing of acetic acid-induced gastric ulcer in rats.Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis.Regulation of gelatinase B (MMP-9) in leukocytes by plant lectins.The transcription factors Sp1, Sp3, and AP-2 are required for constitutive matrix metalloproteinase-2 gene expression in astroglioma cells.Matrix metalloproteinase-2 (MMP-2) and membrane-type 1 MMP (MT1-MMP) affect the remodeling of glomerulosclerosis in diabetic OLETF rats.
P2860
Q24311377-78C37ED6-72C0-4DD8-BD13-39317CC187B4Q24535055-CD938CE3-7512-4A7A-A101-D071A081A7ABQ28115039-7DA1AFBD-2CDD-46C3-BEF8-231645CFD944Q28205871-EFCA99D4-4869-43E6-A350-A777CEBF196AQ28289998-C3C7E6F9-6F47-4E47-A197-E66E97ABAF1DQ28575331-A9B109DC-F5B8-4A51-8426-7178BAE3114AQ28584826-A5803880-F3F4-42BC-8949-5CF2179C39A6Q33424911-7BDFD8CF-E294-4766-96BE-14D78544C637Q34125244-F0EB6B13-3FEF-4356-8EFC-6E276CC43CE0Q34360984-ED16A156-83AC-406E-A691-A1818100E80EQ34441751-4AA0E2DE-7BE3-42C9-9EC6-F2C0530F162FQ35778695-61FAF939-F957-4B8F-88FB-53F9B0085D82Q35812185-BFB55507-9E3C-441F-B80E-6C861ED6B76EQ36372650-7B5B60C2-8FCC-4621-9707-00F5C7DA0A08Q36418892-AC6AF3B5-4237-4942-9396-28610C8B4658Q36879994-67CA02C2-6518-4D07-B313-E8C3B1351574Q37246924-9912CF0A-43A0-4EBF-8367-5A025429E784Q38346730-5005B3BE-929A-4911-8E03-3B8C6FCFFCDBQ38611997-6BDAFDCA-09BC-4D8D-B783-CAE684EF1CEBQ39084573-D2DEC7F3-EA6B-4031-9AE3-9E130D38189FQ40023735-48BABAEC-E978-4458-826D-3FA62BDB90FBQ40474751-B975C15F-8953-4588-8CFA-279B6E2B0C1EQ40982613-CC45D6CC-D537-4B69-952C-6833A2123B7AQ42446009-ABA6450D-FB00-476A-A06F-B659D1BAD359Q46044860-4C373C7E-CFF3-47CD-96DF-F64F789D5F87Q47332898-A912095E-6353-48D7-AFFF-6E8C889BB4B4Q47677996-CA8203D1-6834-4A83-A08C-6D4B611BB04EQ48025649-86AE386D-889C-490E-B08A-8DC9062DA5B5Q52573380-9BE212FD-BB09-4F9D-A770-625D74265A64Q53260748-34A9C7AA-7E77-4771-9299-F3F33EE907CB
P2860
Tissue-specific enhancer-promoter interactions regulate high level constitutive expression of matrix metalloproteinase 2 by glomerular mesangial cells.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Tissue-specific enhancer-promo ...... by glomerular mesangial cells.
@en
Tissue-specific enhancer-promo ...... by glomerular mesangial cells.
@nl
type
label
Tissue-specific enhancer-promo ...... by glomerular mesangial cells.
@en
Tissue-specific enhancer-promo ...... by glomerular mesangial cells.
@nl
prefLabel
Tissue-specific enhancer-promo ...... by glomerular mesangial cells.
@en
Tissue-specific enhancer-promo ...... by glomerular mesangial cells.
@nl
P2093
P2860
P356
P1476
Tissue-specific enhancer-promo ...... by glomerular mesangial cells.
@en
P2093
Harendza S
Mertens PR
Pollock AS
P2860
P304
18786-18796
P356
10.1074/JBC.270.32.18786
P407
P577
1995-08-01T00:00:00Z